Fund shareholders of Kymera Therapeutics Inc
ISIN US5015751044 · United States
- Fund shareholders
- 328
- Of which ETFs
- 56 272 other funds
- Value held
- 3.2B $ 14.3M SEK
- Share of capital
- 45.0 % of 83.2M shares on Jul 31, 2026
328 funds hold this company. This table lists the 327 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 498 | 41.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 486 | 40.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Clearwater Select Equity Fund Clearwater Investment Trust | 479 | 39.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 426 | 38.9K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 425 | 34.5K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 363 | 29.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 334 | 27.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 280 | 23.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 274 | 22.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 271 | 22.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 263 | 21.3K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 216 | 18K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Managed Volatility V.I. Fund BlackRock Variable Series Funds, Inc. | 210 | 17.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 192 | 16K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 174 | 14.1K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 163 | 13.6K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 145 | 12.1K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 129 | 10.7K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 113 | 9.2K $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 105 | 8.5K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 103 | 8.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 77 | 6.4K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 58 | 5.3K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 58 | 4.8K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 25 | 2.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 18 | 1.6K $ | 0.15 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 15 | 1.2K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 4.66 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 3.28 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 2.08 % | as of Mar 31, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.76 % | as of Apr 30, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 1.74 % | as of Apr 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.50 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.46 % | as of Apr 30, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 1.39 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 1.35 % | as of Feb 27, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 1.27 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 326 | +46 | 37,368,607 | +19.2 % |
| 2026Q1 | 280 | +34 | 31,349,132 | +16.0 % |
| 2025Q4 | 246 | +17 | 27,025,402 | +2.7 % |
| 2025Q3 | 229 | +20 | 26,320,167 | +5.4 % |
| 2025Q2 | 209 | -17 | 24,978,847 | +3.3 % |
| 2025Q1 | 226 | -3 | 24,181,745 | -0.4 % |
| 2024Q4 | 229 | +7 | 24,277,044 | +9.0 % |
| 2024Q3 | 222 | +8 | 22,274,447 | -1.1 % |
| 2024Q2 | 214 | +9 | 22,529,228 | +36.8 % |
| 2024Q1 | 205 | -9 | 16,467,458 | -17.7 % |
| 2023Q4 | 214 | 20,020,316 |
Institutional managers
248 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 11,699,950 | 974.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 8,657,242 | 721.1M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 7,474,747 | 622.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6,060,847 | 504.8K $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,502,710 | 458.3M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,464,997 | 455.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,060,876 | 421.5M $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 4,578,008 | 381.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,889,687 | 324M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,186,830 | 265.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,389,767 | 199M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 1,673,275 | 139.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,645,350 | 137.1M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 1,043,583 | 86.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,023,852 | 85.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 888,409 | 74M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 888,035 | 69.1M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 875,872 | 73M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 836,759 | 69.7M $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 772,165 | 64.3M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 759,848 | 63.3M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 750,000 | 62.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 626,925 | 52.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 592,879 | 49.4M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 561,170 | 46.7M $ | as of Mar 31, 2026 |
Declared shareholders of Kymera Therapeutics Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 14.30 % | 11,681,450 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 6.70 % | 5,460,257 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 10 others | 6.30 % | 5,237,151 | as of Jun 26, 2026 · SCHEDULE 13D |
| Wellington Management Group LLP and 2 others | 4.80 % | 3,889,687 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Kymera Therapeutics Inc". https://titelia.com/en/stocks/kymera-therapeutics-inc-US5015751044